Lv41
760 积分 2023-01-14 加入
Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective
1小时前
待确认
The theory of tumor ecosystem
2个月前
已完结
Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis
2个月前
已完结
Evolutionary trajectories of small cell lung cancer under therapy
2个月前
已完结
The evolution of lung cancer and impact of subclonal selection in TRACERx
3个月前
已完结
Tolerance in the Age of Immunotherapy
3个月前
已完结
EP08.02-029 Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations: Effect of Prior Treatment
8个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
8个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
8个月前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
8个月前
已完结
皖公网安备34019202002308
